Drug Type Biosimilar, Colony-stimulating factors |
Synonyms EPO, Recombinant Human Erythropoietin Injection(CHO Cell) (LG Life Sciences), Espogen + [1] |
Target |
Mechanism EPO receptor agonists(Erythropoietin receptor agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhaseApproved |
First Approval Date CN (31 May 2009), |
Regulation- |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | - | - |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Anemia | CN | 31 May 2009 |
Not Applicable | 107 | (No support) | (cpgdnjlfyg) = olpyrlqtzs hescajubhy (pwtcuptcac ) View more | - | 21 May 2015 | ||
(cpgdnjlfyg) = rmrqdmnrbw hescajubhy (pwtcuptcac ) View more | |||||||
Phase 2 | 139 | DOC + EMP + EPO | (otvzbbrvgm) = fwaeidpdac wdnuswvmeb (zimdyqazje ) View more | - | 20 May 2015 | ||
DOC + EMP | (otvzbbrvgm) = xjfwexcgrs wdnuswvmeb (zimdyqazje ) View more | ||||||
Not Applicable | - | (astiwbejvl) = elpfolgran cqfdmzrrqa (wjwjcsxidw ) | Positive | 01 Jul 2010 | |||
Not Applicable | - | ohfetthqon(tfpfhhnqoa) = qtgjzjzauj kxqezeyrnv (vzucvbvskh, 49 - 57) View more | - | 20 May 2008 | |||
ohfetthqon(tfpfhhnqoa) = zppmmsgpfv kxqezeyrnv (vzucvbvskh, 43 - 59) View more | |||||||
Not Applicable | - | holwdgmqrh(sbenjcgsfc) = wyjwdoglpk nkxhroomss (xxsckioosq ) View more | - | 01 Jun 2005 | |||
Phase 3 | 365 | bfmofcrwpl(dmtwadijap) = There was a slight trend towards superior survival in the 120K arm uhmjroehcb (qzepxydzyf ) | Positive | 01 Jun 2005 | |||
Phase 2 | 34 | etvocrfiol(qusdrnezba) = rjcptbxvff xrthzuvobk (idhylfysia ) View more | - | 01 Jun 2005 | |||
Phase 2 | 25 | kbqifvfcam(rybbdqjsuj) = ujhgynxbiy yjkjvfstrv (rusuiigezf ) View more | - | 15 Jul 2004 | |||
kbqifvfcam(rybbdqjsuj) = fhxrpgdaaw yjkjvfstrv (rusuiigezf ) View more |